RxDoctor Payments DataLook up a doctor →

Guillermo Lievano, DO

Obstetrics & Gynecology · Miami, FLNPI 1992785026

Payments from drug & device makers

$2,533,495in general payments, 2019–2025

Across 245 payments — averaging $10,341 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$2.2M
  • Sumitomo Pharma America, Inc.$167K
  • AbbVie$122K
  • Myovant Sciences GmbH$46K
  • Bayer$9K
  • Myovant Sciences Inc.$4K
  • plus $5K from 21 others

What the payments were for

  • Travel & lodging$1,01515%
  • Food & beverage$2,66239%
  • Education$3,11846%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,533,495 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$2,878
Medicare patients
17
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →